Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools

American Journal of Health-System Pharmacy

Volumn 69, Issue 3, 2012, Pages 221-227

  Wright, Adam ^a   Feblowitz, Joshua ^a   Phansalkar, Shobha ^a   Liu, Jialin ^b   Wilcox, Allison ^a   Keohane, Carol A ^c   Seger, Diane L ^d   Bloomrosen, Meryl ^d   Kuperman, Gilad J ^e   Bates, David W ^f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SICHUAN UNIVERSITY   (China)

^c BWH   (United States)

^d American Medical Informatics Association   (United States)

^e NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^f BHW   (United States)

Author keywords

Computers; Drug interactions; Drugs, adverse reactions; Errors, medication; Hospitals; Medication orders

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIGOXIN; FENTANYL; FUROSEMIDE; GLYCERYL TRINITRATE; HALOPERIDOL; HEPARIN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; HYDROXYZINE; LEVOFLOXACIN; LISINOPRIL; LORAZEPAM; METOPROLOL; MORPHINE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PROCHLORPERAZINE; PROMETHAZINE; PROPOFOL; QUETIAPINE; TEMAZEPAM; VECURONIUM; WARFARIN; ZOLPIDEM;

ADVERSE DRUG REACTION; ARTICLE; ASPIRATION; BRADYCARDIA; COMMUNITY HOSPITAL; COMPUTERIZED PROVIDER ORDER ENTRY; CONFUSION; CONSCIOUSNESS; DECISION SUPPORT SYSTEM; HEMATOCRIT; HOSPITAL PATIENT; HUMAN; HYPOTENSION; HYPOVENTILATION; HYPOXIA; INTERNATIONAL NORMALIZED RATIO; LETHARGY; MENTAL DISEASE; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RETROSPECTIVE STUDY; SIDE EFFECT; SLURRED SPEECH; SOMNOLENCE; THROMBOCYTOPENIA;

EID: 84863244171     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110084     Document Type: Article

References (25)

1. Berga Cullere C, Gorgas Torner MQ, Altimiras Ruiz J et al. [Detecting ADEs during the hospital stay]. Farm Hosp. 2009; 33:312-23. In Spanish.
2. Cano FG, Rozenfeld S. Adverse drug events in hospitals: a systematic review. Cad Saude Publica. 2009; 25(suppl 3):S360-72.
3. Nicholson D, Hersh W, Gandhi TK et al. Medication errors: not just a few "bad apples." J Clin Outcomes Manag. 2006; 13:114-5.
4. Bates DW, Cullen DJ, Laird N et al., for the ADE Prevention Study Group. Incidence of ADEs and potential ADEs. Implications for prevention. JAMA. 1995; 274:29-34.
5. Leape LL, Brennan TA, Laird N et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991; 324:377-84.
6. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997; 277:301-6. (Pubitemid 27045010)
7. Bates DW, Spell N, Cullen DJ et al., for the Adverse Drug Events Prevention Study Group. The costs of ADEs in hospitalized patients. JAMA. 1997; 277:307-11.
8. Bates DW, Leape LL, Cullen DJ et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998; 280:1311-6. (Pubitemid 28473716)
9. Bates DW, Teich JM, Lee J et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc. 1999; 6:313-21. (Pubitemid 29328569)
10. Van Rosse F, Maat B, Rademaker CM et al. The effect of computerized physician order entry on medication prescription errors and clinical outcome in pediatric and intensive care: a systematic review. Pediatrics. 2009; 123:1184-90.
11. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med. 2003; 163:1409-16. (Pubitemid 36758913)
12. Kaushal R, Jha AK, Franz C et al. Return on investment for a computerized physician order entry system. J Am Med Inform Assoc. 2006; 13:261-6.
13. Hug BL, Witkowski DJ, Sox CM et al. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention. J Gen Intern Med. 2009; 25:31-8.
14. Phansalkar S, Wright A, Kuperman GJ et al. Towards meaningful medicationrelated clinical decision support: recommendations for an initial implementation. Appl Clin Inform. 2011; 2:50-62.
15. Massachusetts Technology Collaborative. About the CPOE Initiative. www.masstech.org/ehealth/cpoe.html (accessed 2011 May 20).
16. Kaushal R, Jaggi T, Walsh K et al. Pediatric medication errors: what do we know? What gaps remain? Ambul Pediatr. 2004; 4:73-81. (Pubitemid 38180876)
17. Mann K, Rothschild JM, Keohane CA et al. Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification. World J Biol Psychiatry. 2008; 9:24-33. (Pubitemid 351250517)
18. Morimoto T, Gandhi TK, Seger AC et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004; 13:306-14. (Pubitemid 39070900)
19. Bates DW, Boyle DL, Vander Vliet MB et al. Relationship between medication errors and ADEs. J Gen Intern Med. 1995; 10:199-205.
20. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003; 12:194-200. (Pubitemid 36723946)
21. Griffin FA, Resar RK. IHI global trigger tool for measuring adverse events (second edition). www.ihi.org/NR/ rdonlyres/B277159C-60D4-4EFD- BF2AB9FB62CAAA4A/ 0/IHIGlobalTrigger ToolWhitePaper2009.pdf (accessed 2011 May 20).
22. National Library of Medicine, National Institutes of Health. An overview of Rx- Norm. www.nlm.nih.gov/research/umls/ rxnorm/overview.html (accessed 2010 Dec 22).
23. Brown SH, Elkin PL, Rosenbloom ST et al. VA National Drug File Reference Terminology: a cross-institutional content coverage study. Stud Health Technol Inform. 2004; 107(pt 1):477-81.
24. Food and Drug Administration. Frequently asked questions about combination products. www.fda.gov/ Combination Products/About CombinationProducts/ucm101496.htm (accessed 2010 Nov 22).
25. Michna E, Duh MS, Korves C et al. Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications. Pain Med. 2010; 11:369-78.